Oppenheimer Asset Management’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-9,579
Closed -$391K 1152
2023
Q1
$391K Buy
9,579
+944
+11% +$38.5K 0.01% 903
2022
Q4
$333K Sell
8,635
-3,968
-31% -$153K 0.01% 941
2022
Q3
$670K Sell
12,603
-1,338
-10% -$71.1K 0.01% 765
2022
Q2
$813K Sell
13,941
-5,413
-28% -$316K 0.01% 730
2022
Q1
$1.48M Sell
19,354
-690
-3% -$52.7K 0.02% 630
2021
Q4
$1.21M Sell
20,044
-1,237
-6% -$74.4K 0.02% 721
2021
Q3
$1.19M Buy
21,281
+1,844
+9% +$103K 0.02% 689
2021
Q2
$1.18M Buy
19,437
+3,521
+22% +$214K 0.02% 698
2021
Q1
$1.12M Buy
15,916
+3,302
+26% +$232K 0.02% 688
2020
Q4
$755K Buy
12,614
+4,949
+65% +$296K 0.01% 775
2020
Q3
$461K Buy
7,665
+3,060
+66% +$184K 0.01% 836
2020
Q2
$242K Buy
4,605
+3,114
+209% +$164K 0.01% 985
2020
Q1
$50K Buy
1,491
+897
+151% +$30.1K ﹤0.01% 1262
2019
Q4
$27K Sell
594
-123
-17% -$5.59K ﹤0.01% 1421
2019
Q3
$27K Sell
717
-7,049
-91% -$265K ﹤0.01% 1426
2019
Q2
$338K Sell
7,766
-175
-2% -$7.62K 0.01% 925
2019
Q1
$302K Buy
7,941
+188
+2% +$7.15K 0.01% 937
2018
Q4
$333K Sell
7,753
-1,410
-15% -$60.6K 0.01% 867
2018
Q3
$450K Sell
9,163
-98
-1% -$4.81K 0.01% 848
2018
Q2
$297K Sell
9,261
-2,601
-22% -$83.4K 0.01% 950
2018
Q1
$370K Buy
11,862
+4,487
+61% +$140K 0.01% 865
2017
Q4
$277K Hold
7,375
0.01% 950
2017
Q3
$277K Buy
7,375
+4,976
+207% +$187K 0.01% 954
2017
Q2
$114K Buy
+2,399
New +$114K ﹤0.01% 1161